InvestorsHub Logo
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Re: trading.jeff post# 35335

Saturday, 05/21/2016 7:17:11 PM

Saturday, May 21, 2016 7:17:11 PM

Post# of 48316
I think Pierce has done his job and there's not much value he can add by being present there 9 to 5 as they wait for the P2B data. Contingent on this data, interim to be precise, my opinion is that OncoSec may see an offer in the next year or so. Whether it's from Merck or some company like Gilead who's lagging behind in the cancer treatment field. IMO, of course.

http://www.bidnessetc.com/69179-gilead-sciences-gild-turn-acquisitions-drive-future-growth/